Blovacitinib

Overview

Blovacitinib (TUL01101) is a potent, selective and orally active JAK1 inhibitor, with an IC 50 s of 3, 37, 1517 and 36 nM for JAK1 , JAK2 , JAK3 , and TYK2 , respectively. Blovacitinib can be used for the research of rheumatoid arthritis.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > JAK

Product Information

• Catalog No.: HY-152080
• CAS No.: 2411222-97-2
• Molecular Formula: C22H25F2N5O2
• Molecular Weight: 429.46
• Purity: 99.71%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (5.82 mM); Clear solution
• Availability: In-stock

Source

Original product source